CYP2D6: Novel genomic structures and alleles

Pharmacogenetics and Genomics

Volumn 19, Issue 10, 2009, Pages 813-822

  Kramer, Whitney E ^a   Walker, Denise L ^a   O'Kane, Dennis J ^b   Mrazek, David A ^a   Fisher, Pamela K ^b   Dukek, Brian A ^b   Bruflat, Jamie K ^b   Black, John L ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Allele; CYP2D6; CYP2D7; CYP2D8; Cytochrome P450; Drug metabolism; Pharmacogenetics; Polymorphism; Recombinant

Indexed keywords

CYTOCHROME P450 2D6;

ALLELE; ARTICLE; CHROMOSOME DUPLICATION; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENE DUPLICATION; GENE STRUCTURE; GENETIC RECOMBINATION; GENOTYPE; HOMOZYGOSITY; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; CYTOCHROME P-450 CYP2D6; GENE DUPLICATION; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 70349568746     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283317b95     Document Type: Article

References (39)

1. Black J III, O'Kane D, Mrazek D. The impact of CYP2D6 allelic variation on antidepressant drug metabolism: a review. Expert Opin Drug Metabol Toxicol 2007; 3:21-31.
2. Kirchheiner J, Nickchen K, Bauer M, Wong M-L, Licinio J, Roots I, et al. Pharmacogenomics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiat 2004; 9:442-473.
3. Goetz M, Knox S, Suman V, Rae J, Safgren S, Ames M, et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007; 101:113-121.
4. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenetics Genomics 2007; 17:93-101.
5. Lovlie R, Daly A, Molven A, Idle J, Steen V. Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett 1996; 392:30-34.
6. Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, Meyer U. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet 1991; 48:943-950.
7. Johansson I, Lundqvist E, Bertilsson L, Dahl M-L, Sjoqvist F. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 1993; 90:11825-11829.
8. Steen V, Andreassen O, Daly A, Tefre T, Borresen A, Idle J, Gulbrandsen A. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics 1995; 5:215-223.
9. Steen V, Molven A, Aarskog N, Gulbrandsen A-K. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the human cytochrome P450 CYP2D6 gene. Hum Mol Genet 1995; 4:2251-2257.
10. Gaedigk A, Ndjountche L, Divakaran K, DiAnne Bradford L, Zineh I, Oberlander T, et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clinical Pharmacol Therap 2007; 81:242-251.
11. Chida M, Ariyoshi N, Yokoi T, Nemoto N, Inaba T, Kinoshita M, et al. New allelic arrangement CYP2D6*36 x 2 found in a Japanese poor metabolizer of debrisoquine. Pharmacogenetics 2002; 12:659-662.
12. Daly A, Fairbrother K, Andreassen O, London S, Idle J, Steen V. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics 1996; 6:319-328.
13. Johansson I, Oscarson M, Yue Q-Y, Bertilsson L, Sjoqvist F, Ingelman-Sundberg M. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 1994; 46:452-459.
14. Gaedigk A, DiAnne Bradford L, Alander SW, Steven Leeder J. CYP2D6*36 gene arrangements within the CYP2D6 locus: associations of CYP2D6*36 with poor metabolizer status. Drug Metab Dispos 2006; 34:563-569.
15. Ingelman-Sundberg M. Genetic Polymorphisms of cytochrome p450 2D6 (CYP2D6) clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005; 5:6-13.
16. Panserat S, Mura C, Gerard N, Vincent-Viry M, Galteau M, Jacqz-Aigrain E, et al. An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype. Br J Clin Pharmacol 1995; 40:361-367.
17. Zanger U, Fischer J, Raimundo S, Stuven T, Evert B, Schwab M, et al. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 2001; 11:573-585.
18. Sakuyama K, Sasaki T, Ujiie S, Obata K, Mizugaki M, Ishikawa M, et al. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57). Drug Metab Dispos 2008; 36:2460-2467.
19. Fukuda T, Maune H, Ikenaga Y, Naohara M, Fukuda K, Azuma J. Novel structure of the CYP2D6 gene that confuses genotyping for the CYP2D6*5 allele. Drug Metabol Pharmacokinet 2005; 20:345-350.
20. Stankiewicz P, Lupski J. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002; 18:74-82.
21. Lundqvist E, Johansson I, Ingelman-Sundberg M. Genetic mechanisms for duplication and multiduplication of the CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 1999; 226:327-338.
22. Carroll S, DeRose M, Gaudray P, Moore C, Needham-Vandevanter D, Von Hoff D, et al. Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol 1988; 8:1525-1533.
23. Carroll S, Gaudray P, DeRose M, Emery J, Meinkoth J, Nakkim E, et al. Characterization of an episome produced in hamster cells that amplify a transfected CAD gene at high frequency: functional evidence for a mammalian replication origin. Mol Cell Biol 1987; 7:1740-1750.
24. Hahn P. Molecular biology of double-minute chromosomes. BioEssays 1993; 15:477-484.
25. Stanfield S, Helinski D. Small circular DNA in Drosophila melanogaster. Cell 1976; 9:333-345.
26. Cohen S, Agmon N, Yacobi K, Mislovati M, Segal D. Evidence for rolling circle replication of tandem genes in Drosophila. Nucleic Acids Res 2005; 33:4519-4526.
27. Cohen S, Yacobi K, Segal D. Extrachromosomal circular DNA of tandemly repeated genomic sequences in drosophila. Genome Res 2003; 13:1133-1145.
28. Cohen S, Mechali M. A novel cell-free system reveals a mechanism of circular DNA formation from tandem repeats. Nucleic Acids Res 2001; 29:2542-2548.
29. Cohen S, Mechali M. Formation of extrachromosomal circles from telomeric DNA in Xenopus laevis. EMBO Rep 2002; 3:1168-1174.
30. Tlsty T, Brown P, Schimke R. UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells. Mol Cell Biol 1984; 4:1050-1056.
31. Von Hoff D, Forseth B, Clare C, Hansen K, VanDevanter D. Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells. J Clin Invest 1990; 85:1887-1895.
32. Beland J, Longo J, Hahn P. CpG island mapping of a mouse double-minute chromosome. Mol Cell Biol 1993; 13:4459-4464.
33. Carroll S, DeRose M, Kolman J, Nonet G, Kelly R, Wahl G. Localization of a bidirectional DNA replication origin in the native locus and in episomally amplified murine adenosine deaminase loci. Mol Cell Biol 1993; 13:2971-2981.
34. Cohen S, Lavi S. Induction of circles of heterogeneous sizes in carcinogen-treated cells: two-dimensional gel analysis of circular DNA molecules. Mol Cell Biol 1996; 16:2002-2014.
35. Van Loon N, Miller D, Murnane J. Formation of extrachromosomal circular DNA in HeLa cells by nonhomologous recombination. Nucleic Acids Res 1994; 22:2447-2452.
36. Schaeffeler E, Schwab M, Eichelbaum M, Zanger U. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 2003; 22:476-485.
37. Schimke R. Gene amplification, drug resistance and cancer. Cancer Res 1984; 44:1735-1742.
38. Stark G. DNA amplification in drug resistant cells and in tumors. Cancer Surv 1986; 5:1-5.
39. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-182.